ETIHX Holdings — Eventide Healthcare & Life Sciences Fund
All 93 reported holdings of Eventide Healthcare & Life Sciences Fund (ETIHX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Guardant Health, Inc. | 5.37% | $96.07M |
| US Bank Mmda | 3.75% | $67.01M |
| Mirum Pharmaceuticals, Inc. | 3.47% | $62.08M |
| Kymera Therapeutics, Inc. | 3.22% | $57.68M |
| Abivax SA | 2.94% | $52.61M |
| BeLite Bio Inc | 2.83% | $50.60M |
| Trevi Therapeutics, Inc. | 2.77% | $49.61M |
| Mbx Biosciences, Inc. | 2.69% | $48.22M |
| Vaxcyte, Inc. | 2.69% | $48.10M |
| Cytokinetics, Inc. | 2.69% | $48.05M |
| Argenx SE | 2.55% | $45.64M |
| Ionis Pharmaceuticals, Inc. | 2.55% | $45.59M |
| Insmed, Inc. | 2.40% | $43.01M |
| Revolution Medicines, Inc. | 2.36% | $42.18M |
| Avalyn Pharma, Inc. | 2.35% | $41.99M |
| Immix Biopharma, Inc. | 2.24% | $40.12M |
| Celldex Therapeutics, Inc. | 2.16% | $38.59M |
| Palvella Therapeutics, Inc. | 1.98% | $35.38M |
| Kestra Medical Technologies Ltd. | 1.95% | $34.81M |
| Scholar Rock Holding Corp. | 1.95% | $34.80M |
| Apogee Therapeutics, Inc. | 1.93% | $34.51M |
| Definium Therapeutics, Inc. | 1.87% | $33.40M |
| Irhythm Holdings, Inc. | 1.85% | $33.04M |
| Bridgebio Pharma, Inc. | 1.82% | $32.56M |
| Beta Bionics, Inc. | 1.80% | $32.16M |
| Nurix Therapeutics, Inc. | 1.76% | $31.49M |
| Arrowhead Pharmaceuticals, Inc. | 1.69% | $30.16M |
| Disc Medicine, Inc. | 1.62% | $28.91M |
| Ovid Therapeutics, Inc. | 1.49% | $26.57M |
| Cg Oncology, Inc. | 1.46% | $26.03M |
| Amylyx Pharmaceuticals, Inc. | 1.33% | $23.80M |
| Oruka Therapeutics, Inc. | 1.28% | $22.84M |
| First American Funds, Inc. | 1.25% | $22.36M |
| Dianthus Therapeutics, Inc. | 1.23% | $21.96M |
| Sionna Therapeutics, Inc. | 1.17% | $20.89M |
| Celcuity, Inc. | 1.14% | $20.46M |
| Glaukos Corp. | 1.11% | $19.94M |
| Sutro Biopharma, Inc. | 1.09% | $19.43M |
| Privia Health Group, Inc. | 1.06% | $18.98M |
| Eyepoint, Inc. | 1.00% | $17.81M |
| Spyre Therapeutics, Inc. | 0.99% | $17.76M |
| Heartflow, Inc. | 0.98% | $17.46M |
| Dexcom, Inc. | 0.95% | $17.01M |
| Aktis Oncology, Inc. | 0.91% | $16.34M |
| Achieve Life Sciences, Inc. | 0.81% | $14.50M |
| United Therapeutics Corp. | 0.80% | $14.40M |
| Axsome Therapeutics, Inc. | 0.77% | $13.71M |
| Kailera Therapeutics, Inc. | 0.76% | $13.59M |
| Praxis Precision Medicines, Inc. | 0.72% | $12.82M |
| Tango Therapeutics, Inc. | 0.70% | $12.50M |
| Evommune, Inc. | 0.70% | $12.49M |
| Kardium Inc. | 0.60% | $10.82M |
| Oric Pharmaceuticals, Inc. | 0.58% | $10.30M |
| Belite Bio, Inc. | 0.54% | $9.58M |
| Bright Minds Biosciences, Inc. | 0.51% | $9.13M |
| Adlai Nortye Ltd. | 0.46% | $8.27M |
| Kardigan, Inc. | 0.40% | $7.16M |
| Relmada Therapeutics, Inc. | 0.39% | $7.03M |
| Adlai Nortye Ltd. | 0.36% | $6.51M |
| Inhibrx Biosciences, Inc. | 0.33% | $5.83M |
| Relmada Therapeutics, Inc. | 0.33% | $5.83M |
| Transmedics Group, Inc. | 0.31% | $5.49M |
| Ovid Therapeutics, Inc. | 0.29% | $5.20M |
| InMed Pharma Inc | 0.28% | $5.10M |
| Pfizer, Inc. | 0.24% | $4.32M |
| Fidelity Colchester Street Trust | 0.21% | $3.69M |
| Evommune, Inc. | 0.20% | $3.58M |
| Ovid Therapeutics Inc | 0.20% | $3.54M |
| Avalyn Pharma, Inc. | 0.18% | $3.29M |
| Ideaya Biosciences, Inc. | 0.14% | $2.42M |
| Freenome Holdings, Inc. | 0.13% | $2.28M |
| Peloton Therapeutics | 0.10% | $1.74M |
| Prometheus Biosciences | 0.05% | $980.82K |
| Casma Therapeutics Ii | 0.04% | $726.31K |
| Flare Therapeutics, Inc. | 0.02% | $408.18K |
| Casma Therapeutics | 0.02% | $401.93K |
| Casma Therapeutics | 0.02% | $401.93K |
| Flare Therapeutics Incorporated | 0.02% | $335.62K |
| Freenome | 0.02% | $327.78K |
| Casma Therapeutics Ii | 0.01% | $199.35K |
| Casma Therapeutics, Inc. | 0.01% | $146.33K |
| Biosplice Therapeutics Inc. Series C | 0.00% | $83.21K |
| Goldfinch Biopharma, Inc. | 0.00% | $44.02K |
| Goldfinch Bio B2 | 0.00% | $26.58K |
| Kojin Therapeutics, Inc. | 0.00% | $0 |
| Biosplice Therapeutics Inc. | 0.00% | $0 |
| Goldfinch Bio, Inc. | 0.00% | $0 |
| Kojin Therapeutics | 0.00% | $0 |
| Goldfinch Biopharma, Inc. | 0.00% | $0 |
| Biosplice Therapeutics | 0.00% | $0 |
ETIHX overview: performance, fees, allocation and SEC filings